Trial intelligence / Profile preview

Pilot Study of Low Dose Bowel Prep (Moviprep) for Colonoscopy

NCT00321230Phase 2Completed

Sponsor
Norgine
Start
Jan 2001
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of macrogol in bowel preparation, sponsored by Norgine. Primary endpoint: Overall quality of colonoscopy prep. Started Jan 2001; status: completed.

02

Drugs

macrogol
03

Conditions

bowel preparation

Beyond the preview

Go deeper on NCT00321230.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00321230.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call